IS8368A - Ný aðferð - Google Patents
Ný aðferðInfo
- Publication number
- IS8368A IS8368A IS8368A IS8368A IS8368A IS 8368 A IS8368 A IS 8368A IS 8368 A IS8368 A IS 8368A IS 8368 A IS8368 A IS 8368A IS 8368 A IS8368 A IS 8368A
- Authority
- IS
- Iceland
- Prior art keywords
- new method
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702065A SE510650C2 (sv) | 1997-05-30 | 1997-05-30 | Ny förening |
Publications (2)
Publication Number | Publication Date |
---|---|
IS8368A true IS8368A (is) | 2006-03-22 |
IS2774B IS2774B (is) | 2012-03-15 |
Family
ID=20407186
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5272A IS2142B (is) | 1997-05-30 | 1999-11-25 | Nýtt form S-ómeprasóls |
IS8368A IS2774B (is) | 1997-05-30 | 2006-03-22 | Ný aðferð til að framleiða tríhýdrat magnesíumsalt S-ómeprasóls |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5272A IS2142B (is) | 1997-05-30 | 1999-11-25 | Nýtt form S-ómeprasóls |
Country Status (44)
Families Citing this family (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
WO1997025429A1 (en) | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6369087B1 (en) * | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
AU2003208686A1 (en) * | 2002-03-05 | 2003-09-16 | Astrazeneca Ab | Alkylammonium salts of omeprazole and esomeprazole |
WO2003089408A2 (en) * | 2002-04-22 | 2003-10-30 | Sun Pharmaceutical Industries Limited | Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
EP1515963B1 (en) * | 2002-06-27 | 2007-02-14 | Dr. Reddy's Laboratories Ltd. | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
CN100378093C (zh) * | 2002-06-27 | 2008-04-02 | 雷迪实验室有限公司 | 一种制备包括无定形艾美拉唑及其盐在内的光学纯或光学浓缩的亚砜化合物的方法 |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
AU2003262992A1 (en) * | 2002-08-30 | 2004-03-19 | Reddy's Laboratories Limited | Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
CA2502219C (en) * | 2002-10-16 | 2012-05-29 | Takeda Pharmaceutical Company Limited | A process for producing an amorphous isomer of lansoprazole |
WO2004037253A1 (en) * | 2002-10-22 | 2004-05-06 | Ranbaxy Laboratories Limited | Amorphous form of esomeprazole salts |
WO2004046134A2 (en) * | 2002-11-18 | 2004-06-03 | Dr. Reddy's Laboratories Limited | Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation |
WO2004060263A2 (en) * | 2003-01-07 | 2004-07-22 | Ranbaxy Laboratories Limited | Magnesium salt of imidazole derivative |
AU2003238671A1 (en) * | 2003-04-10 | 2004-11-01 | Hetero Drugs Limitd | Novel crystalline forms of s-omeprazole magnesium |
US20070060556A1 (en) | 2003-05-05 | 2007-03-15 | Yatendra Kumar | Barium salt of benzimidazole derivative |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2532774A1 (en) * | 2003-07-23 | 2005-02-10 | Altana Pharma Ag | Alkaline salts of proton pump inhibitors |
CN100457104C (zh) * | 2003-07-23 | 2009-02-04 | 尼科梅德有限责任公司 | 质子泵抑制剂的碱性盐 |
SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts I |
SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
JP2007523164A (ja) * | 2004-02-18 | 2007-08-16 | アラーガン、インコーポレイテッド | プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物 |
WO2005082337A2 (en) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Compositions comprising prodrugs of proton pump inhibitors |
MXPA06011820A (es) * | 2004-04-16 | 2006-12-15 | Santarus Inc | Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico. |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050267157A1 (en) * | 2004-05-28 | 2005-12-01 | David White | Magnesium-S-omeprazole |
US20050267159A1 (en) * | 2004-05-28 | 2005-12-01 | Aaipharma, Inc. | Magnesium complexes of S-omeprazole |
CA2570916C (en) | 2004-06-16 | 2013-06-11 | Tap Pharmaceutical Products, Inc. | Pulsed release dosage form of a ppi |
CN103772360A (zh) * | 2004-06-24 | 2014-05-07 | 阿斯利康(瑞典)有限公司 | 制备用于制备艾美拉唑钠盐的结晶修饰物的新方法 |
ES2246149B1 (es) * | 2004-07-02 | 2007-06-01 | Esteve Quimica, S.A. | Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion. |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US20060160783A1 (en) * | 2004-12-30 | 2006-07-20 | Transform Pharmaceuticals, Inc. | Novel omeprazole forms and related methods |
ES2259269B1 (es) | 2005-03-03 | 2007-11-01 | Esteve Quimica, S.A. | Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos. |
US20060210637A1 (en) * | 2005-03-17 | 2006-09-21 | Qpharma, Llc | Stable tablet dosage forms of proton pump inhibitors |
KR20080007508A (ko) * | 2005-05-06 | 2008-01-21 | 그렌마크 파머수티칼스 엘티디. | 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물 |
EP1891043A1 (en) * | 2005-06-15 | 2008-02-27 | Hetero Drugs Limited | Amorphous esomeprazole hydrate |
EP1904064A4 (en) * | 2005-07-07 | 2009-12-02 | Reddys Lab Ltd Dr | OMEPRAZOLE OF FORM B |
KR100641534B1 (ko) | 2005-07-28 | 2006-11-01 | 한미약품 주식회사 | 에스오메프라졸 및 그의 염의 제조방법 |
US20070026071A1 (en) * | 2005-07-28 | 2007-02-01 | Qpharma, Llc | Magnesium salt proton pump inhibitor dosage forms |
WO2007031845A2 (en) * | 2005-09-14 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation |
JP2009511481A (ja) * | 2005-10-06 | 2009-03-19 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 増強された治療特性を持つ、胃H+,K+−ATPaseの重水素化阻害剤 |
WO2007049914A1 (en) * | 2005-10-26 | 2007-05-03 | Hanmi Pharm. Co., Ltd. | S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same |
US7576219B2 (en) | 2005-10-26 | 2009-08-18 | Hanmi Pharm. Co., Ltd | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
US7553857B2 (en) * | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
CN100384839C (zh) * | 2006-02-17 | 2008-04-30 | 中国科学院上海有机化学研究所 | [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法 |
US7579476B2 (en) * | 2006-02-24 | 2009-08-25 | Praktikatalyst Pharma, Llc | Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
US8063074B2 (en) | 2006-05-04 | 2011-11-22 | Dr. Reddy's Laboratories Limited | Polymorphic forms of esomeprazole sodium |
US20100286208A1 (en) * | 2006-06-21 | 2010-11-11 | Bobba Venkata Siva Kumar | Novel polymorph of esomeprazole potassium and process for its preparation |
GB2459393B (en) | 2006-10-05 | 2010-09-08 | Santarus Inc | Novel capsule formulation for the proton pump inhibitor omeprazole |
WO2008057802A2 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
EP1947099A1 (en) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
WO2008092939A2 (en) | 2007-01-31 | 2008-08-07 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation |
KR101522865B1 (ko) * | 2007-02-21 | 2015-05-26 | 시플라 리미티드 | 에소메프라졸 마그네슘 2수화물의 형태 a의 제조방법 |
KR101303813B1 (ko) * | 2007-04-16 | 2013-09-04 | 에스케이케미칼주식회사 | 라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법 |
EP2000468A1 (en) | 2007-05-09 | 2008-12-10 | Dr. Reddy's Laboratories Ltd. | Esomeprazole salts and processes for preparation thereof |
EP2152691B1 (en) * | 2007-06-07 | 2011-11-23 | Aurobindo Pharma Limited | An improved process for preparing an optically active proton pump inhibitor |
FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
WO2009047775A2 (en) * | 2007-10-08 | 2009-04-16 | Hetero Drugs Limited | Polymorphs of esomeprazole salts |
RU2010119041A (ru) | 2007-10-12 | 2011-11-20 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи |
WO2009074997A2 (en) * | 2007-12-10 | 2009-06-18 | Lee Pharma Ltd. | A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate |
WO2009099933A2 (en) * | 2008-02-01 | 2009-08-13 | Dr. Reddy's Laboratories Ltd. | Preparation of esomeprazole magnesium and hydrates thereof |
WO2009137648A1 (en) * | 2008-05-09 | 2009-11-12 | Aptapharma, Inc. | Multilayer proton pump inhibitor tablets |
US20090280173A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Omeprazole Tablets |
EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
EP2147918A1 (en) * | 2008-07-21 | 2010-01-27 | LEK Pharmaceuticals D.D. | Process for the preparation of S-omeprazole magnesium in a stable form |
CA2736547C (en) | 2008-09-09 | 2016-11-01 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
CN101391993B (zh) * | 2008-10-28 | 2012-07-04 | 安徽美诺华药物化学有限公司 | 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法 |
WO2010097583A1 (en) | 2009-02-24 | 2010-09-02 | Cipla Limited | Esomeprazole potassium polymorph and its preparation |
US20100267959A1 (en) * | 2009-04-15 | 2010-10-21 | Glenmark Generics Limited | Process for the preparation of esomeprazole magnesium dihydrate |
WO2010122583A2 (en) | 2009-04-24 | 2010-10-28 | Rubicon Research Private Limited | Oral pharmaceutical compositions of acid labile substances |
WO2010150276A2 (en) * | 2009-06-02 | 2010-12-29 | Sun Pharmaceutical Industries Limited | Process for preparing sulphoxide compounds |
KR20120093140A (ko) * | 2009-06-25 | 2012-08-22 | 포젠 인크. | 아스피린 치료를 필요로 하는 환자의 치료 방법 |
CN102481293A (zh) | 2009-06-25 | 2012-05-30 | 阿斯利康(瑞典)有限公司 | 治疗具有发展nsaid-相关的溃疡的风险的患者的方法 |
WO2011012957A1 (en) * | 2009-07-29 | 2011-02-03 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of esomeprazole magnesium dihydrate |
WO2011058569A1 (en) | 2009-11-12 | 2011-05-19 | Hetero Research Foundation | Process for the resolution of omeprazole |
SI2510089T1 (sl) | 2009-12-08 | 2015-12-31 | Codexis, Inc. | Sinteza prazolnih spojin |
US20110207779A1 (en) * | 2010-02-25 | 2011-08-25 | Glenmark Generics Ltd | Process for the preparation of esomeprazole magnesium |
FR2959509B1 (fr) | 2010-05-03 | 2012-07-13 | Prod Chim Auxiliaires Et De Synthese | Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole |
CN102241668B (zh) * | 2010-05-11 | 2015-11-25 | 中国科学院成都有机化学有限公司 | S-奥美拉唑盐 |
EP2649187B1 (en) | 2010-12-08 | 2017-11-22 | Codexis, Inc. | Biocatalysts and methods for the synthesis of armodafinil |
CN102757421A (zh) * | 2011-04-29 | 2012-10-31 | 江苏正大天晴药业股份有限公司 | 埃索美拉唑的纯化方法 |
CN104844577A (zh) * | 2011-07-31 | 2015-08-19 | 连云港润众制药有限公司 | 埃索美拉唑镁的晶型 |
CN102924435B (zh) * | 2011-11-25 | 2014-06-25 | 成都自豪药业有限公司 | S-奥美拉唑镁盐的晶型及其制备方法 |
WO2013088272A1 (en) * | 2011-12-14 | 2013-06-20 | Wockhardt Limited | Pharmaceutical composition comprising esomeprazole magnesium dihydrate |
EA028049B1 (ru) | 2011-12-28 | 2017-10-31 | Поузен Инк. | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты |
CN102584792B (zh) * | 2012-01-06 | 2014-06-11 | 南京优科生物医药研究有限公司 | 制备高纯度的埃索美拉唑盐的方法 |
CN102993184A (zh) * | 2013-01-08 | 2013-03-27 | 湖南方盛制药股份有限公司 | 一种埃索美拉唑及其镁盐三水合物的制备方法 |
CN104250243B (zh) * | 2013-06-27 | 2016-12-28 | 四川国为制药有限公司 | 一种埃索美拉唑镁二水合物a晶型的制备方法 |
CN103570686B (zh) * | 2013-10-14 | 2015-04-01 | 哈药集团技术中心 | 一种埃索美拉唑钠的合成及精制工艺 |
CN104725357A (zh) * | 2013-12-24 | 2015-06-24 | 苏州联友制药技术有限公司 | 一种埃索美拉唑镁二水合物晶型b的制备方法 |
FR3018812A1 (fr) | 2014-03-21 | 2015-09-25 | Minakem | Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole |
CN104447699A (zh) * | 2014-12-10 | 2015-03-25 | 哈药集团技术中心 | 一种埃索美拉唑镁三水合物的制备方法 |
CN105111188B (zh) * | 2015-08-19 | 2018-01-19 | 扬子江药业集团有限公司 | 一种埃索美拉唑镁三水合物晶型的制备方法 |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
CN106397402B (zh) * | 2016-08-30 | 2019-05-03 | 山东罗欣药业集团股份有限公司 | 一种埃索美拉唑镁晶型化合物及其制备方法 |
KR102080023B1 (ko) | 2018-01-29 | 2020-02-21 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 |
KR102006777B1 (ko) | 2018-01-29 | 2019-10-08 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제 |
JP7506892B2 (ja) * | 2018-08-21 | 2024-06-27 | 東和薬品株式会社 | 化合物の特定形状の結晶及びその製造方法 |
KR102432084B1 (ko) | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5204118A (en) | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
DE4035455A1 (de) | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
US5360582A (en) | 1991-07-15 | 1994-11-01 | Minnesota Mining And Manufacturing Company | Nonlinear optical materials containing polar disulfone-functionalized molecules |
US5877192A (en) | 1993-05-28 | 1999-03-02 | Astra Aktiebolag | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
FR2719045B1 (fr) * | 1994-04-20 | 1996-05-31 | Rhone Poulenc Chimie | Procédé de préparation d'acide L-aspartique à partir d'aspartate d'ammonium. |
DK1078628T3 (da) | 1994-07-08 | 2009-02-23 | Astrazeneca Ab | Tabletteret flerenhedsdoseringsform |
FR2722191B1 (fr) * | 1994-07-08 | 1996-08-23 | Rhone Poulenc Rorer Sa | Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle |
SE504459C2 (sv) | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
CA2205206A1 (en) * | 1994-11-14 | 1996-05-23 | Akihiko Miyadera | Hydrate for drug use |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
SE9500422D0 (sv) | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
CN1042423C (zh) | 1995-05-25 | 1999-03-10 | 常州市第四制药厂 | 奥美拉唑盐水合物及其制备方法 |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
US6747155B2 (en) * | 1997-05-30 | 2004-06-08 | Astrazeneca Ab | Process |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
AR057181A1 (es) | 2005-11-30 | 2007-11-21 | Astra Ab | Nueva forma de dosificacion de combinacion |
-
1997
- 1997-05-30 SE SE9702065A patent/SE510650C2/sv not_active IP Right Cessation
-
1998
- 1998-05-05 US US09/077,719 patent/US6369085B1/en not_active Expired - Lifetime
- 1998-05-15 HR HR980263A patent/HRP980263B1/xx not_active IP Right Cessation
- 1998-05-18 ZA ZA984179A patent/ZA984179B/xx unknown
- 1998-05-18 DZ DZ980105A patent/DZ2495A1/xx active
- 1998-05-18 TW TW087107675A patent/TW538040B/zh not_active IP Right Cessation
- 1998-05-18 AR ARP980102299A patent/AR012717A1/es active IP Right Grant
- 1998-05-21 MA MA25085A patent/MA26500A1/fr unknown
- 1998-05-25 PL PL98337180A patent/PL193546B1/pl unknown
- 1998-05-25 UA UA99116288A patent/UA60334C2/uk unknown
- 1998-05-25 ES ES02019642T patent/ES2236407T3/es not_active Expired - Lifetime
- 1998-05-25 ME MEP-180/08A patent/MEP18008A/xx unknown
- 1998-05-25 RU RU99128072/04A patent/RU2184115C2/ru active Protection Beyond IP Right Term
- 1998-05-25 ME MEP-249/08A patent/MEP24908A/xx unknown
- 1998-05-25 AT AT02019642T patent/ATE291574T1/de active
- 1998-05-25 NZ NZ500991A patent/NZ500991A/en not_active IP Right Cessation
- 1998-05-25 PT PT98926005T patent/PT984957E/pt unknown
- 1998-05-25 ME MEP-2008-249A patent/ME00198B/me unknown
- 1998-05-25 CN CNB98805521XA patent/CN1161351C/zh not_active Expired - Lifetime
- 1998-05-25 DE DE69814069.9T patent/DE69814069T3/de not_active Expired - Lifetime
- 1998-05-25 JP JP50057899A patent/JP4002303B2/ja not_active Expired - Lifetime
- 1998-05-25 SI SI9830761T patent/SI1273581T1/xx unknown
- 1998-05-25 BR BR9809509-9A patent/BR9809509A/pt not_active Application Discontinuation
- 1998-05-25 RS RSP-2007/0459A patent/RS50067B/sr unknown
- 1998-05-25 KR KR1019997011106A patent/KR100540720B1/ko not_active IP Right Cessation
- 1998-05-25 SK SK76-2005A patent/SK285137B6/sk not_active IP Right Cessation
- 1998-05-25 SI SI9830424T patent/SI0984957T1/xx unknown
- 1998-05-25 EE EEP199900550A patent/EE03875B1/xx active Protection Beyond IP Right Term
- 1998-05-25 TR TR1999/02934T patent/TR199902934T2/xx unknown
- 1998-05-25 SK SK1625-99A patent/SK284837B6/sk not_active IP Right Cessation
- 1998-05-25 DK DK98926005T patent/DK0984957T3/da active
- 1998-05-25 CZ CZ20041090A patent/CZ297585B6/cs not_active IP Right Cessation
- 1998-05-25 EP EP02019642A patent/EP1273581B1/en not_active Expired - Lifetime
- 1998-05-25 RS YUP-609/99A patent/RS50005B/sr unknown
- 1998-05-25 AT AT98926005T patent/ATE239011T1/de active
- 1998-05-25 DE DE69829511T patent/DE69829511T2/de not_active Expired - Lifetime
- 1998-05-25 DK DK02019642T patent/DK1273581T3/da active
- 1998-05-25 EP EP98926005.4A patent/EP0984957B3/en not_active Expired - Lifetime
- 1998-05-25 HU HU0001849A patent/HU225987B1/hu active Protection Beyond IP Right Term
- 1998-05-25 WO PCT/SE1998/000974 patent/WO1998054171A1/en active Application Filing
- 1998-05-25 PT PT02019642T patent/PT1273581E/pt unknown
- 1998-05-25 ID IDW991449A patent/ID29306A/id unknown
- 1998-05-25 CA CA002521391A patent/CA2521391C/en not_active Expired - Lifetime
- 1998-05-25 CA CA002290963A patent/CA2290963C/en not_active Expired - Lifetime
- 1998-05-25 AU AU77935/98A patent/AU722839B2/en not_active Expired
- 1998-05-25 ES ES98926005.4T patent/ES2195345T7/es active Active
- 1998-05-25 IL IL13294798A patent/IL132947A0/xx not_active IP Right Cessation
- 1998-05-25 KR KR10-2005-7006896A patent/KR100527804B1/ko not_active IP Right Cessation
- 1998-05-27 EG EG58098A patent/EG24291A/xx active
- 1998-05-29 TN TNTNSN98074A patent/TNSN98074A1/fr unknown
- 1998-05-29 MY MYPI98002399A patent/MY120745A/en unknown
- 1998-05-29 MY MYPI20032997A patent/MY127793A/en unknown
- 1998-07-12 SA SA98190280A patent/SA98190280B1/ar unknown
- 1998-07-12 SA SA5260296A patent/SA05260296B1/ar unknown
-
1999
- 1999-11-25 IS IS5272A patent/IS2142B/is unknown
- 1999-11-29 NO NO19995852A patent/NO317518B1/no not_active IP Right Cessation
-
2000
- 2000-08-17 HK HK00105176A patent/HK1025962A1/xx not_active IP Right Cessation
- 2000-08-17 HK HK03103300A patent/HK1051681A1/xx not_active IP Right Cessation
-
2002
- 2002-02-14 US US10/076,711 patent/US6677455B2/en not_active Expired - Lifetime
-
2003
- 2003-09-25 US US10/672,936 patent/US7411070B2/en not_active Expired - Fee Related
-
2006
- 2006-03-22 IS IS8368A patent/IS2774B/is unknown
-
2007
- 2007-02-20 AR ARP070100714A patent/AR059589A2/es active IP Right Grant
- 2007-03-16 JP JP2007068061A patent/JP2007161734A/ja active Pending
- 2007-09-11 US US11/853,323 patent/US7745466B2/en not_active Expired - Fee Related
-
2010
- 2010-05-21 US US12/784,881 patent/US8076361B2/en not_active Expired - Fee Related
-
2011
- 2011-06-07 NO NO2011010C patent/NO2011010I1/no not_active Application Discontinuation
- 2011-09-19 LU LU91871C patent/LU91871I2/fr unknown
- 2011-11-17 US US13/298,373 patent/US8466175B2/en not_active Expired - Fee Related
-
2012
- 2012-03-26 DE DE201212000017 patent/DE122012000017I1/de active Pending
- 2012-06-05 NO NO2012011C patent/NO2012011I1/no unknown
- 2012-06-06 LU LU92017C patent/LU92017I2/fr unknown
- 2012-11-05 CY CY2012029C patent/CY2012029I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8368A (is) | Ný aðferð | |
ATA93198A (de) | Fluoxetinpellets | |
PT1036083E (pt) | Novos 9a-azalidos | |
IS5106A (is) | Ný aðferð | |
DE69828227D1 (de) | Aufzeichnungsverfahren | |
NO20003079D0 (no) | Polymerisasjon-oppstartningsprosess | |
NO20003080D0 (no) | Polymerisasjon-oppstartningsprosess | |
DK0983266T3 (da) | Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider | |
ATA111897A (de) | Kimme | |
ATE236897T1 (de) | 3-benzylpiperidine | |
ATA112597A (de) | Snowboard - bindung | |
FI972592A (fi) | Synkronointimenetelmä | |
BR9711681A (pt) | Novos m-todos | |
ID17503A (id) | Metoda konstruksi | |
FI974067A0 (fi) | Process foer cellulasbehandling | |
ATA195097A (de) | Korbartiger baustein | |
ATA86797A (de) | Verschleissschuh | |
AR008310A1 (es) | Metodos nuevos | |
FI103308B1 (fi) | Synkronointimenetelmä | |
ID21138A (id) | Teknologi film-tipis untuk head-drum | |
ID19172A (id) | Metoda penstabilan | |
ATA46498A (de) | Kunststoffgleitbahn | |
SE9800172D0 (sv) | New method | |
SE9804191D0 (sv) | New method | |
ID16281A (id) | Metode |